Parabilis Medicines
PBLS
28.82
-0.04
-0.14%
Parabilis Medicines
US · PBLS
#2366 by market cap
Listed 2026
28.82
-0.04
-0.14%
Live - 5344 symbols - heartbeat 297s ago
· 2026-10-08 07:36
Pre-market
28.80
-0.07%
After-hours
28.82
0.00%
- Market cap
- 3.56B
- P/E (TTM)i
- -15.17
- P/Bi
- 3.40
- EPSi
- -1.82
- Div yieldi
- 0.00%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on PBLS?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 3 analysts
Buy
Avg price target
42.33 +46.9%
Price target rangecurrent 28.82
Low40.00
Avg42.33
High45.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (9)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-16 | BofA Securities | -- | BUY | 45.00 |
| 2026-08-14 | BofA Securities | -- | BUY | -- |
| 2026-08-14 | Guggenheim | -- | BUY | 40.00 |
| 2026-08-13 | LifeSci Capital | -- | BUY | 42.00 |
| 2026-07-18 | LifeSci Capital | -- | BUY | 42.00 |
| 2026-07-06 | BofA Securities | -- | BUY | 45.00 |
| 2026-07-06 | Evercore | -- | BUY | -- |
| 2026-07-06 | Leerink Partners | -- | BUY | 40.00 |
| 2026-07-05 | Guggenheim | -- | BUY | 40.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-08 07:36:25 · For reference only, not investment advice and not tailored to your situation.